semaglutide glucose Semaglutide: A Comprehensive Research Overview PDB-101: Diabetes Mellitus: Diabetes Mellitus:

Semaglutides ability to target obesity, inflammation (via CRP), and metabolic dysfunction aligns well with a precision medicine approach, wherein therapy is tailored to distinct phenotypes within HFpEF

TGR5 Signaling in Hepatic Metabolic Health

Employers who win in this space: Lead with behavior change Set medication boundaries Require outcome tracking Build a clinical off-ramp With the right design, covering GLP-1s becomes more than a benefit it becomes a business case for long-term health, productivity, and cost control

Reza Hashemian, covering the clinical, the societal, and the personal

Diabetes, Obesity & Metabolism, 20(2), 378-388

As cardiologists and intensivists, we need to be critical of the tracings themselves, avoid anchoring to a single value, and be observant of the overall hemodynamic trajectory our patient is taking